Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Comparison of Random Periareolar Fine Needle Aspirate versus Ductal Lavage for Risk Assessment and Prevention of Breast Cancer.

Hoffman A, Pellenberg R, Drendall CI, Seewaldt V.

Curr Breast Cancer Rep. 2012 Sep;4(3):180-187. Epub 2012 Jun 22.

2.

Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials.

Arun B, Valero V, Logan C, Broglio K, Rivera E, Brewster A, Yin G, Green M, Kuerer H, Gong Y, Browne D, Hortobagyi GN, Sneige N.

Clin Cancer Res. 2007 Aug 15;13(16):4943-8.

3.

Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer.

Zalles CM, Kimler BF, Simonsen M, Clark JL, Metheny T, Fabian CJ.

Breast Cancer Res Treat. 2006 May;97(2):191-7. Epub 2005 Dec 2.

PMID:
16322885
4.

Assessment of RNA in human breast tissue sampled by random periareolar fine needle aspiration and ductal lavage and processed as fixed or frozen specimens.

Phillips TA, Fabian CJ, Kimler BF, Petroff BK.

Reprod Biol. 2013 Mar;13(1):75-81. doi: 10.1016/j.repbio.2013.01.179. Epub 2013 Feb 19.

PMID:
23522074
5.

Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimens.

Sharma P, Klemp JR, Simonsen M, Welsko CM, Zalles CM, Kimler BF, Fabian CJ.

Breast Cancer Res Treat. 2004 Sep;87(1):59-64.

PMID:
15377851
6.

Breast-tissue sampling for risk assessment and prevention.

Fabian CJ, Kimler BF, Mayo MS, Khan SA.

Endocr Relat Cancer. 2005 Jun;12(2):185-213. Review.

7.

Reproducibility of random periareolar fine needle aspiration in a multi-institutional Cancer and Leukemia Group B (CALGB) cross-sectional study.

Ibarra-Drendall C, Wilke LG, Zalles C, Scott V, Archer LE, Lem S, Yee LD, Lester J, Kulkarni S, Murekeyisoni C, Wood M, Wilson K, Garber J, Gentry C, Stouder A, Broadwater G, Baker JC Jr, Vasilatos SN, Owens E, Rabiner S, Barron AC, Seewaldt VL.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1379-85. doi: 10.1158/1055-9965.EPI-08-1210. Epub 2009 Apr 21.

8.

Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model.

Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Kamel S, Zeiger S, Mayo MS.

J Natl Cancer Inst. 2000 Aug 2;92(15):1217-27.

PMID:
10922407
9.

Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention.

Goldenberg VK, Seewaldt VL, Scott V, Bean GR, Broadwater G, Fabian C, Kimler B, Zalles C, Lipkus IM.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):1032-4.

10.

The role of ductal lavage in the management of women at high risk for breast carcinoma.

Khan SA.

Curr Treat Options Oncol. 2004 Apr;5(2):145-51. Review.

PMID:
14990208
12.

Estrogen receptor expression in benign breast ductal cells obtained from random periareolar fine needle aspiration correlates with menopausal status and cytomorphology index score.

Sharma P, Kimler BF, Warner C, Metheny T, Xue Q, Zalles CM, Fabian CJ.

Breast Cancer Res Treat. 2006 Nov;100(1):71-6. Epub 2006 Jun 22.

PMID:
16791479
13.

Ki-67 expression in benign breast ductal cells obtained by random periareolar fine needle aspiration.

Khan QJ, Kimler BF, Clark J, Metheny T, Zalles CM, Fabian CJ.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):786-9.

15.

Biomarkers for risk assessment and prevention of breast cancer.

Cazzaniga M, Decensi A, Bonanni B, Luini A, Gentilini O.

Curr Cancer Drug Targets. 2009 Jun;9(4):482-99. Review.

PMID:
19519317
16.

Karyometry of breast epithelial cells acquired by random periareolar fine needle aspiration in women at high risk for breast cancer.

Bartels PH, Fabian CJ, Kimler BF, Ranger-Moore JR, Frank DH, Yozwiak ML, Alberts DS.

Anal Quant Cytol Histol. 2007 Apr;29(2):63-70.

PMID:
17484269
17.
18.

Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways.

Ibarra-Drendall C, Troch MM, Barry WT, Broadwater G, Petricoin EF 3rd, Wulfkuhle J, Liotta LA, Lem S, Baker JC Jr, Ford AC, Wilke LG, Zalles C, Kuderer NM, Hoffman AW, Shivraj M, Mehta P, Williams J, Tolbert N, Lee LW, Pilie PG, Yu D, Seewaldt VL.

Breast Cancer Res Treat. 2012 Apr;132(2):487-98. doi: 10.1007/s10549-011-1609-9. Epub 2011 Jun 7. Erratum in: Breast Cancer Res Treat. 2012 Oct;135(3):925.

19.

Ductal lavage for detection of cellular atypia in women at high risk for breast cancer.

Dooley WC, Ljung BM, Veronesi U, Cazzaniga M, Elledge RM, O'Shaughnessy JA, Kuerer HM, Hung DT, Khan SA, Phillips RF, Ganz PA, Euhus DM, Esserman LJ, Haffty BG, King BL, Kelley MC, Anderson MM, Schmit PJ, Clark RR, Kass FC, Anderson BO, Troyan SL, Arias RD, Quiring JN, Love SM, Page DL, King EB.

J Natl Cancer Inst. 2001 Nov 7;93(21):1624-32.

PMID:
11698566

Supplemental Content

Support Center